- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Adam G. Sowatzka
Insights 23 results
Newsletter
June 13, 2022
Focus on Forever – June 13, 2022
Newsletter
March 10, 2022
Focus on Forever – March 10, 2022
Client Alert
January 26, 2022
Spotlight on PFAS and Other Substances in Cosmetics Likely to Grow in 2022
Article · Source: Law360
January 25, 2022
How New Laws Could Tighten FDA Regulation Of Cosmetics
Newsletter
December 13, 2021
Focus on Forever– December 13, 2021
Newsletter
November 2, 2021
Focus on Forever - November 2, 2021
Client Alert
October 21, 2021
EPA’s PFAS Strategic Roadmap Sets Broad and Ambitious Goals
Client Alert
October 20, 2021
US EPA Issues Draft Strategic Plan
Newsletter
October 19, 2021
Focus on Forever – October 19, 2021
Client Alert
September 13, 2021
U.S. EPA and CalEPA Launch Joint Effort to Strengthen Enforcement in Environmental Justice Communities
Client Alert
March 26, 2021
California Proposes Designating PFOA as a Carcinogen under Proposition 65
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry